- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Preclinical Phase
Recent news which mentions Preclinical Phase
RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants
April 11, 2022
Tickers
RDHL
From Benzinga
Shattuck Labs SL-9258 /Anti-PD(L)1 Shows Broadened Anti-Tumor Activity In CPI-Resistant Cancers
April 11, 2022
From Benzinga
From Benzinga
Cellectis Reveals Preclinical Data On First Allogeneic Dual CAR T-Cell Product In Non-Hodgkin Lymphoma
April 11, 2022
Tickers
CLLS
From Benzinga
Hoth Therapeutics' Novel Cancer Drug Prevented Cell Growth, Induced Cell Death Over 72 hours
April 11, 2022
Tickers
HOTH
From Benzinga
Surface Oncology Highlights New SRF388 Data At AACR Meeting
April 11, 2022
Tickers
SURF
From Benzinga
From Benzinga
Codiak BioSciences' Precision Medicine Approach Shows Potent Activity In Cancer Models
April 11, 2022
Tickers
CDAK
From Benzinga
Nurix Therapeutics' BTK Programs Show Encouraging Preclinical Action In Blood Cancer, Solid Tumors
April 11, 2022
Tickers
NRIX
From Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Tickers
ADXN
From Benzinga
EXCLUSIVE: Sunshine Biopharma's Newly Designed mRNA Molecules Effective Against Multidrug Resistant Cancer Cells
April 05, 2022
Tickers
SBFM
From Benzinga
VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis
March 30, 2022
Tickers
VYNE
From Benzinga
Regulus Starts Preclinical Studies In ALS Under Pact With Brigham and Women's Hospital
March 24, 2022
Tickers
RGLS
From Benzinga
Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
March 23, 2022
From Benzinga
Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants
March 21, 2022
Tickers
SRNE
From Benzinga
Stealth BioTherapeutics Showcases New Nonclinical Data From Duchenne Muscular Dystrophy Program
March 17, 2022
Tickers
MITO
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
From Benzinga
FDA Lifts Clinical Hold on Immunome's COVID-19 Candidate IND
March 11, 2022
Tickers
IMNM
From Benzinga
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate
March 10, 2022
Tickers
OGEN
From Benzinga
VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder
March 07, 2022
Tickers
VYNE
From Benzinga
Chimerix's CMX521 Antiviral Program Shows Potential Against COVID-19 In Preclinical Studies
February 24, 2022
Tickers
CMRX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.